We are pleased to announce a strategic shift in our Stainless Steel Bioreactor Engineering and Manufacturing capabilities. For many years, stainless steel bioreactors and fermenters have been the preferred solution for cell and microbial cultivations in biopharmaceutical and industrial biotechnological applications, thanks to their durability, resistance to corrosion, and ease of cleaning, making them ideal for both research and large-scale production.
As we move forward, our focus will transition towards Hybrid Facilities, integrating Stainless Steel Bioreactors with Single-use unit operations in both Upstream and Downstream processes. We will gradually phase out our standalone Stainless Steel Bioreactor business, including Biostat® Cplus and Biostat® D-DCU bioreactors, with sales continuing until early 2025.
Nevertheless, we remain committed to supporting our stainless steel solutions on a smaller scale and in specific cases, recognizing their continued value in certain applications. Please reach out to us for more information on how these changes may affect your operations and to discuss any specific needs you may have.
For more than 50 years, Sartorius Stedim Biotech has been serving the biotechnology industry globally with leading edge cultivation systems. Our international engineering and manufacturing teams have delivered numerous pilot scale and production systems worldwide.
Our centers of excellence in bioprocess engineering ensure highest quality standards through a strong local structure, aligned with the company-wide quality management system.
